The Human Urate Transportosome: Evolutionary Dynamics, Molecular Mechanisms, and Pharmacogenetic Perspectives
Medical Sciences · 2026
DOI: 10.3390/medsci14060612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, 2026. Verfasst von Lilya U Dzhemileva und 5 weiteren Autor:innen. Beteiligte Einrichtung: N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Uric Acid, Pharmacogenetics. Die Arbeit nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The hominoid loss of urate oxidase (uricase) represents a classic evolutionary trade-off, shifting uric acid (UA) from a metabolic waste product to a potent physiological modulator. In modern metabolic environments, however, this adaptation drives hyperuricemia and gout, transforming UA into a primary pathological substrate.
Objective
This review aims to dissect the molecular architecture and biophysical networks of the renal and intestinal urate transportosome, delineate the dual intracellular/extracellular “urate paradox,” and synthesize genotype-based pharmacogenetic strategies to achieve personalized clinical management. Mechanistic Insights: During the Miocene epoch, inactivating pseudogenization of the UOX gene fixed a novel metabolic phenotype characterized by fructose-driven lipid deposition and enhanced antioxidant protection. Structurally, systemic urate homeostasis is strictly governed by a macromolecular interactome assembled by the four-domain scaffold protein PDZK1 on the epithelial apical membrane. Pathogenic gain-of-function variants in reabsorption facilitators (SLC22A12/URAT1, SLC2A9/GLUT9) or loss-of-function mutations in the efflux pump (ABCG2/BCRP) disrupt this delicate vector kinetics. Within the extracellular space, soluble urate acts as a critical hydrophilic radical scavenger. Paradoxically, upon URAT1/GLUT9-mediated internalization or intracellular supersaturation, intracellular urate triggers a pro-oxidant cascade mediated by NADPH oxidase (NOX4) activation and mitochondrial electron transport chain decoupling. This chronic cellular stress activates downstream p38 MAPK and NF-κB signaling pathways, driving localized endothelial injury and macrovascular inflammation, while crystalline monosodium urate (MSU) orchestrates NLRP3 inflammasome assembly in macrophages. Pharmacogenetic Implications: Striking ethno-geographic heterogeneity dictates immediate clinical stratification. The HLA-B*58:01 allele, an absolute molecular contraindication for allopurinol due to life-threatening severe cutaneous adverse reactions (SCARs), exhibits a critical genetic gradient in northern and eastern Eurasian populations, surging from under 1% in ethnic Caucasians to over 10% in indigenous populations of East/North Asian ancestry. Furthermore, structural defects in ABCG2 (such as the p.Q141K variant) alter the ATP-binding cassette domain, inducing standard allopurinol resistance and elevated statin exposure, which mandates a therapeutic pivot toward selective xanthine oxidase inhibitors (febuxostat) or precision uricosurics (benzbromarone, dotinurad) matched to the patient’s interactive network profile.
Conclusions
Transitioning from generalized epidemiological guidelines to a comprehensive “transportosome genetic passport” is a fundamental prerequisite for predicting single-nucleotide polymorphism (SNP)-driven therapeutic responses and mitigating visceral complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, Moscow 119991, Russia.
- Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, Moscow 119121, Russia.
- JSC "Medsi Group of Companies", Michurinsky Prospekt 56/1, Moscow 119192, Russia.
- Department of Medical Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa 450008, Russia.
- Department of Propaedeutics of Internal Diseases No. 2, Institute of Clinical Medicine, Pirogov Russian National Research Medical University, Moscow 117513, Russia.
ORCID-Profile: Lilya U Dzhemileva, Vladimir A D'yakonov, Sergey N Marshala, Elza Khusnutdinova, Andrey A Deviatkin, German A Shipulin
Zitieren
APA
Dzhemileva, L. U., D'yakonov, V. A., Marshala, S. N., Khusnutdinova, E., Deviatkin, A. A., & Shipulin, G. A. (2026). The Human Urate Transportosome: Evolutionary Dynamics, Molecular Mechanisms, and Pharmacogenetic Perspectives. Medical Sciences. https://doi.org/10.3390/medsci14060612
Vancouver
Dzhemileva LU, D'yakonov VA, Marshala SN, Khusnutdinova E, Deviatkin AA, Shipulin GA. The Human Urate Transportosome: Evolutionary Dynamics, Molecular Mechanisms, and Pharmacogenetic Perspectives. Medical Sciences. 2026. doi:10.3390/medsci14060612
BibTeX
@article{Dzhemileva2026,
author = {Dzhemileva, Lilya U and D'yakonov, Vladimir A and Marshala, Sergey N and Khusnutdinova, Elza and Deviatkin, Andrey A and Shipulin, German A},
title = {The Human Urate Transportosome: Evolutionary Dynamics, Molecular Mechanisms, and Pharmacogenetic Perspectives},
journal = {Medical Sciences},
year = {2026},
doi = {10.3390/medsci14060612}
}
EUVIMED